Background and Purpose-Current evidence suggests that the apolipoprotein E (APOE for gene; apoE for protein) ⑀4 allele predisposes to cerebral amyloid angiopathy (CAA) whereas ⑀2 is associated with CAA-related hemorrhage (CAAH). The clinical risk factors for other forms of intracranial hemorrhage are a less-frequent feature of CAAH. In this study we examined potential clinical risk factors in patients with CAAH and assessed these with respect to APOE genotype. Methods-Thirty-six patients were identified with a pathological diagnosis of CAAH. Clinical notes were reviewed to document age of hemorrhage onset, history of dementia, antiplatelet/anticoagulant medication, hypertension, minor head trauma, or transient neurological events. In a review of reported cases of CAAH, the frequency of these clinical features was also recorded. APOE genotypes were determined with use of polymerase chain reaction techniques. Results-There were 24 women and 12 men; the mean age was 70.3 years. One third (nϭ12) had been taking antiplatelet medication, and a similar number were demented. Nine patients were hypertensive, and 4 had a history of recent minor head trauma. The relative frequency of each of these clinical features was similar to that in previous reports. Forty-four percent (16 of 36) possessed an ⑀2 allele. Antiplatelet or anticoagulant medication, hypertension, or minor head trauma were significantly more frequent antecedents of CAAH in ⑀2 carriers than in non-⑀2 carriers (81% versus 35%, Pϭ0.008), antiplatelet/anticoagulant medication in particular (Pϭ0.038). Conclusions-Our findings suggest that antiplatelet or anticoagulant medication, hypertension, or minor head trauma are most likely to precipitate cerebral hemorrhage in patients with CAA who are also ⑀2 carriers. This may result from isoform-specific effects of apoE on the structure of amyloid-laden blood vessel walls. (Stroke. 1999;30:1643-1646.)Key Words: apolipoproteins Ⅲ cerebral amyloid angiopathy Ⅲ intracerebral hemorrhage S poradic cerebral amyloid angiopathy (CAA) is characterized by the deposition of amyloid -protein (A) in small to medium-sized leptomeningeal and cortical blood vessels. The incidence of CAA increases with age, 1 but the process usually remains asymptomatic. However, a minority of patients develop single or multiple CAA-related hemorrhages (CAAH). This observation prompted us to search for specific risk factors (genetic or environmental) that may precipitate hemorrhage from amyloid-laden vessels.Recent evidence implicates the apolipoprotein E gene (APOE) in the etiology of CAAH. 2,3 We previously hypothesized that whereas the APOE ⑀4 allele increases A deposition in the cerebral vasculature, 4 APOE ⑀2 is associated with rupture of A-laden blood vessels, possibly by predisposing to the development of recognized vasculopathic complications of CAA. 2 The clinical risk profile in CAAH has not, however, been firmly established. 5 Although previous reports of CAAH have included patients who were taking antiplatelet or anticoagulant medicatio...